Kailera Therapeutics, Inc. (KLRA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Kailera Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -20.63x |
| P/B Ratio | -8.60x |
| P/S Ratio | 0.00x |
| Profitability | |
| Gross Margin | 0.0% |
| Operating Margin | 0.0% |
| Net Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Liquidity | |
| Current Ratio | 12.01x |
| Quick Ratio | 12.01x |
| Leverage | |
| Debt/Equity | -0.03x |
YoY = year-over-year change. Source: FMP..